Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.
Take one softgel capsule by mouth daily during pregnancy, or as directed by a physician.
www.exeltisusa.comEach Vitafol ® Fe+ softgel capsule contains:
| Vitamin A (as beta carotene) | 330 mcg RAE |
| Vitamin C (as ascorbic acid) | 60 mg |
| Vitamin D (as cholecalciferol) | 25 mcg |
| Vitamin E (as dl-alpha tocopheryl acetate) | 9 mg |
| Thiamin (Vitamin B1 as thiamine mononitrate) | 1.6 mg |
| Riboflavin (Vitamin B2) | 1.8 mg |
| Niacin (as niacinamide) | 15 mg NE |
| Vitamin B6 (as pyridoxine hydrochloride) | 2.5 mg |
| Folate | 1700 mcg DFE |
| (680 mcg DFE from folic acid & 1020 mcg DFE from l-methylfolate calcium) | |
| Vitamin B12 (as cyanocobalamin) | 25 mg |
| Iron (as polysaccharide iron complex) | 90 mg |
| Iodine (as potassium iodide) | 150 mcg |
| Magnesium (as magnesium oxide) | 20 mg |
| Zinc (as zinc oxide) | 25 mg |
| Copper (as copper oxide) | 2 mg |
Docosahexaenoic acid (DHA) (from natural algal oil) | 200 mg |
Other Ingredients:
Gelatin (Bovine), Soybean Oil, Glycerin, Yellow Beeswax, Sorbitol, Soy Lecithin, Titanium Dioxide (color), FD&C Red #40, FD&C Blue #1
Contains: Soy
Vitafol ® Fe + prenatal supplement provides vitamin, mineral and omega-3 fatty acid supplementation throughout pregnancy, including individuals with known allergies to fish.* Vitafol ® Fe + does not contain fish oils, fish proteins, or fish by-products.
Vitafol ® Fe + prenatal supplement is contraindicated in patients with hypersensitivity to any of its components or color additives.
Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid.
Iron supplementation is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver.
Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitamin B12).
Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.
This product is intended for use as directed by your healthcare provider. Do not share with others. Vitafol ® Fe + must be used with caution in patients with known sensitivity or allergy to soy.
Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased risk of heart disease can occur.
Iodine should be used with caution in patients with an overactive thyroid.
Prolonged use of iron salts may produce iron storage disease.
Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive. The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency.
Consumption of more than 3 grams of omega-3 fatty acids per day from all sources may lead to excessive bleeding. Supplemental intake of omega-3 fatty acids such as DHA exceeding 2 grams per day is not recommended.
Avoid Overdosage. Keep out of the reach of children.
Medications for an overactive thyroid (anti-thyroid drugs) used in conjunction with iodine supplementation may lead to hypothyroidism.
Medications for hypertension used in conjunction with iodine supplementation may increase potassium levels in blood.
High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs; carbamazepine, fosphenytoin, phenytoin, phenobarbital, valproic acid. Folic acid may decrease a patient's response to methotrexate.
Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones.
Zinc can inhibit the absorption of certain antibiotics; take at least 2 hours apart to minimize interactions.
Consult appropriate references for additional specific vitamin-drug interactions
Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breast-feeding.
Not for pediatric use.
Adverse reactions have been reported with specific vitamins and minerals, but generally at doses substantially higher than those in Vitafol ® Fe +. However, allergic and idiosyncratic reactions are possible at any dose. Reported adverse events include skin ailments, gastrointestinal complaints, glucose abnormalities, and visual problems.
You should call your doctor for medical advice about adverse or unexpected reactions. To report to the company an adverse event or obtain product information, call 1-877-324-9349.
Take one softgel capsule by mouth daily during pregnancy, or as directed by a physician.
Vitafol ® Fe + is available as a purple, oval shaped softgel capsule imprinted "EX0096". Available in box of Unit-Dose pack of 30 (5 child resistant blister cards containing 6 softgel capsules) (0642-7473-30) and as professional samples (0642-7473-01).
Store at room temperature, approximately 15°-30°C (59°-86°F), avoid excessive heat above 30°C (86°F), light and moisture.
| *These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. |
Rx
Distributed by:
Exeltis USA, Inc.
Florham Park, NJ 07932
1-877-324-9349
www.exeltisusa.com
©2024 Exeltis USA, Inc. All rights reserved.
Vitafol
® is a trademark of Exeltis Healthcare S.L.
4733001-05 July 2024
0642-7473-30
VITAFOL
Fe+
Complete Prenatal Supplement
with 90mg iron
Unit Dose Pack
30 Softgel Capsules
R
X
DIETARY SUPPLEMENT
U.S. Patent Pending
| Class | Version | Type | Effective |
|---|---|---|---|
| ASCORBIC ACID Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CHOLECALCIFEROL Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| CYANOCOBALAMIN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| LEVOMEFOLIC ACID Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20230428 |
| MAGNESIUM CATION Pharmacologic Class Indexing | 4 | Indexing - Pharmacologic Class | 20180813 |
| PYRIDOXINE Pharmacologic Class Indexing | 1 | Indexing - Pharmacologic Class | 20170310 |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0642-7473-30 | 2025-03-18 | C162847 | 48780-1 | e4f33bdf-a844-d8a0-e053-dadaa90a6e4e | 0642-7473-30 Vitafol ® Fe + Supplement Prenatal Supplement with 90 mg Iron Rx |
| 0642-7473-30 | 2023-07-28 | C162847 | 48780-1 | e4f33bdf-a844-d8a0-e053-dadaa90a6e4e | 0642-7473-30 Vitafol ® Fe + Supplement Prenatal Supplement with 90 mg Iron Rx |
| 0642-7473-30 | 2023-02-14 | C162847 | 48780-1 | e4f33bdf-a844-d8a0-e053-dadaa90a6e4e | 0642-7473-30 Vitafol ® Fe + Supplement Prenatal Supplement with 90 mg Iron Rx |
| 0642-7473-30 | 2022-07-29 | C162847 | 48780-1 | e4f33bdf-a844-d8a0-e053-dadaa90a6e4e | 0642-7473-30 Vitafol ® Fe + Supplement Prenatal Supplement with 90 mg Iron Rx |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0642-7473-30 | Vitafol Fe Plus | 5 in 1 BOX, UNIT-DOSE | CAPSULE, LIQUID FILLED | 5 | 6 | |
| 0642-7473-30 | Vitafol Fe Plus | 6 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 6 | 6 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0642-7473 | VITAFOL FE PLUS (DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, BETA CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, IRON, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, FOLIC ACID, AND LEVOMEFOLATE CALCIUM) CAPSULE, LIQUID FILLED [EXELTIS USA, INC.] | 6 | Current NDC, Legacy NDC, 2 package rows | 20250322_3927b074-d72a-4d8c-9f7e-15c42a830945.zip |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0642-7473-30 | EA - Each | 0642-7473 | c1d0c7f5-187b-4488-b0c8-450aafffab4f | 1 | 2020-03-10 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 0642-7473 | 0642-7473-30 |
Every source-derived ingredient row is available through these pages.
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Vitafol Fe Plus | DOCONEXENT, NIACINAMIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, CHOLECALCIFEROL, BETA CAROTENE, ASCORBIC ACID, THIAMINE MONONITRATE, RIBOFLAVIN, PYRIDOXINE HYDROCHLORIDE, CYANOCOBALAMIN, IRON, ZINC OXIDE, CUPRIC OXIDE, POTASSIUM IODIDE, MAGNESIUM OXIDE, FOLIC ACID, AND LEVOMEFOLATE CALCIUM | Exeltis USA, Inc. | 3927b074-d72a-4d8c-9f7e-15c42a830945 | 2025-03-20 | Boxed warning, Warnings, Adverse reactions | 0642-7473-30 0642-7473 00642747330 30c9224d-2f77-3e90-e063-6294a90a9a58 3927b074-d72a-4d8c-9f7e-15c42a830945 |
Adverse event summaries are temporarily unavailable. Other product information remains available.